+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Thrombosis"

From
From
Polycythemia Vera Market Report and Forecast 2024-2032 - Product Thumbnail Image

Polycythemia Vera Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Research & Reviews: Journal of Oncology and Hematology - Product Thumbnail Image

Research & Reviews: Journal of Oncology and Hematology

  • Journal Icon Journal
  • March 2025
  • 66 Pages
  • Global
From
Mastering Structural Heart Disease. Edition No. 1 - Product Thumbnail Image

Mastering Structural Heart Disease. Edition No. 1

  • Book
  • February 2023
  • 672 Pages
Haematology. Edition No. 11. Lecture Notes - Product Thumbnail Image

Haematology. Edition No. 11. Lecture Notes

  • Book
  • November 2022
  • 208 Pages
Loading Indicator

Thrombosis is a medical condition in which a blood clot forms in a blood vessel, obstructing the flow of blood. It is a major concern in hematology, as it can lead to serious complications such as stroke, heart attack, and pulmonary embolism. Treatment of thrombosis typically involves anticoagulants, which are drugs that reduce the ability of the blood to clot. In some cases, thrombolytic drugs may be used to dissolve the clot. The thrombosis market is a rapidly growing segment of the hematology market, driven by the increasing prevalence of thrombosis and the development of new treatments. The market is expected to benefit from the introduction of novel drugs and therapies, as well as the increasing demand for better diagnosis and treatment of thrombosis. Some of the major companies in the thrombosis market include Bayer AG, Pfizer Inc., Sanofi, Bristol-Myers Squibb, and Johnson & Johnson. Show Less Read more